Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic Scottsdale, Scottsdale, Arizona (M.D., F.G., K.H., D.I.P., L.J.M.); Department of Molecular Biology, Scripps Research Institute and Molsoft LLC, La Jolla, California (P.C.-H.L., R.A.); and Department of Pharmacology, Monash University, Clayton, Victoria, Australia (P.M.S.)

Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic Scottsdale, Scottsdale, Arizona (M.D., F.G., K.H., D.I.P., L.J.M.); Department of Molecular Biology, Scripps Research Institute and Molsoft LLC, La Jolla, California (P.C.-H.L., R.A.); and Department of Pharmacology, Monash University, Clayton, Victoria, Australia (P.M.S.)

Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic Scottsdale, Scottsdale, Arizona (M.D., F.G., K.H., D.I.P., L.J.M.); Department of Molecular Biology, Scripps Research Institute and Molsoft LLC, La Jolla, California (P.C.-H.L., R.A.); and Department of Pharmacology, Monash University, Clayton, Victoria, Australia (P.M.S.)

Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic Scottsdale, Scottsdale, Arizona (M.D., F.G., K.H., D.I.P., L.J.M.); Department of Molecular Biology, Scripps Research Institute and Molsoft LLC, La Jolla, California (P.C.-H.L., R.A.); and Department of Pharmacology, Monash University, Clayton, Victoria, Australia (P.M.S.)

Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic Scottsdale, Scottsdale, Arizona (M.D., F.G., K.H., D.I.P., L.J.M.); Department of Molecular Biology, Scripps Research Institute and Molsoft LLC, La Jolla, California (P.C.-H.L., R.A.); and Department of Pharmacology, Monash University, Clayton, Victoria, Australia (P.M.S.)

Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic Scottsdale, Scottsdale, Arizona (M.D., F.G., K.H., D.I.P., L.J.M.); Department of Molecular Biology, Scripps Research Institute and Molsoft LLC, La Jolla, California (P.C.-H.L., R.A.); and Department of Pharmacology, Monash University, Clayton, Victoria, Australia (P.M.S.)

Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic Scottsdale, Scottsdale, Arizona (M.D., F.G., K.H., D.I.P., L.J.M.); Department of Molecular Biology, Scripps Research Institute and Molsoft LLC, La Jolla, California (P.C.-H.L., R.A.); and Department of Pharmacology, Monash University, Clayton, Victoria, Australia (P.M.S.)

Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic Scottsdale, Scottsdale, Arizona (M.D., F.G., K.H., D.I.P., L.J.M.); Department of Molecular Biology, Scripps Research Institute and Molsoft LLC, La Jolla, California (P.C.-H.L., R.A.); and Department of Pharmacology, Monash University, Clayton, Victoria, Australia (P.M.S.)